The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting provided a platform for interaction and exchange among basic scientists and clinicians in breast cancer. Highlights from this hybrid meeting include the latest Phase III data for the use of SERDs for HR+/HER2- disease, updates on the use of IO in TNBC as well as the importance of tackling disparities in breast cancer treatment and survival outcomes.
View all videos

SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting
07–10 December 2021 | San Antonio, TX

We’re here to bring you the highlights of what #lungcancer experts have been discussing on the third day of #TTLC24!

Can’t make it? We’ll be covering all the latest here with exclusive interviews and more at 👉 http://VJOncology.com 👈

@VJOncology @IASLC #LCSM #NSCLC #SCLC

It’s day 2 of #TTLC24, and we’re excited to continue coverage of the latest in targeted therapies for #lungcancer!

Follow us @VJOncology or visit http://VJOncology.com for more information.

@IASLC #LCSM #NSCLC #SCLC

💥 Day 1 of #TTLC24 has arrived, so be sure keep an eye out for all the developments in targeted therapies for #lungcancer!

Don’t forget to visit http://vjoncology.com for exclusive interviews with the speakers!

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More

SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting
07–10 December 2021 | San Antonio, TX
The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting provided a platform for interaction and exchange among basic scientists and clinicians in breast cancer. Highlights from this hybrid meeting include the latest Phase III data for the use of SERDs for HR+/HER2- disease, updates on the use of IO in TNBC as well as the importance of tackling disparities in breast cancer treatment and survival outcomes.
View all videos

We’re here to bring you the highlights of what #lungcancer experts have been discussing on the third day of #TTLC24!

Can’t make it? We’ll be covering all the latest here with exclusive interviews and more at 👉 http://VJOncology.com 👈

@VJOncology @IASLC #LCSM #NSCLC #SCLC

It’s day 2 of #TTLC24, and we’re excited to continue coverage of the latest in targeted therapies for #lungcancer!

Follow us @VJOncology or visit http://VJOncology.com for more information.

@IASLC #LCSM #NSCLC #SCLC

💥 Day 1 of #TTLC24 has arrived, so be sure keep an eye out for all the developments in targeted therapies for #lungcancer!

Don’t forget to visit http://vjoncology.com for exclusive interviews with the speakers!

@VJOncology @IASLC #LCSM #NSCLC #SCLC

Load More